Insys $250M Opioid Penalty for Quality Fraud
Link to the DOJ announcement below: FOR IMMEDIATE RELEASE Wednesday, June 5, 2019 Opioid Manufacturer Insys Therapeutics Agrees to Enter $225 Million Global Resolution of Criminal and Civil Investigations